Handelsbanken Fonder
RVMD icon

Handelsbanken Fonder’s Revolution Medicines RVMD Stock Holding History

Handelsbanken Fonder’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8M Buy
212,275
+150,500
+244% +$22M 0.11% 144
2026
Q1 		$6.01M Buy
61,775
+7,600
+14% +$767K 0.02% 447
2025
Q4 		$4.32M Sell
54,175
-4,200
-7% -$275K 0.01% 517
2025
Q3 		$2.73M Buy
58,375
+11,700
+25% +$458K 0.01% 631
2025
Q2 		$1.72M Buy
46,675
+2,900
+7% +$111K 0.01% 719
2025
Q1 		$1.55M Sell
43,775
-600
-1% -$24.4K 0.01% 750
2024
Q4 		$1.94M Sell
44,375
-2,400
-5% -$121K 0.01% 687
2024
Q3 		$2.12M Buy
46,775
+10,100
+28% +$440K 0.01% 647
2024
Q2 		$1.42M Sell
36,675
-3,500
-9% -$131K 0.01% 694
2024
Q1 		$1.29M Hold
40,175
– – 0.01% 743
2023
Q4 		$1.15M Buy
40,175
+25,975
+183% +$624K 0.01% 747
2023
Q3 		$393K Buy
14,200
+800
+6% +$23.7K ﹤0.01% 1177
2023
Q2 		$358K Buy
13,400
+1,900
+17% +$46.6K ﹤0.01% 1252
2023
Q1 		$249K Hold
11,500
– – ﹤0.01% 1371
2022
Q4 		$274K Hold
11,500
– – ﹤0.01% 1298
2022
Q3 		$227K Hold
11,500
– – ﹤0.01% 1393
2022
Q2 		$224K Hold
11,500
– – ﹤0.01% 1463
2022
Q1 		$293K Sell
11,500
-5,300
-32% -$115K ﹤0.01% 1529
2021
Q4 		$423K Buy
16,800
+4,700
+39% +$132K ﹤0.01% 1462
2021
Q3 		$333K Hold
12,100
– – ﹤0.01% 1563
2021
Q2 		$384K Buy
12,100
+4,100
+51% +$143K ﹤0.01% 1548
2021
Q1 		$367K Hold
8,000
– – ﹤0.01% 1357
2020
Q4 		$317K Buy
+8,000
New +$316K ﹤0.01% 1379

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Handelsbanken Fonder's RVMD Position: Q2 2026 in Review

Handelsbanken Fonder increased its Revolution Medicines (RVMD) stake by 244% in Q2 2026, buying an estimated $22M and bringing the position to 212,275 shares worth $39.8M. The position accounts for 0.11% of the portfolio, ranked #144.

Handelsbanken Fonder first reported a position in RVMD in Q4 2020 and has held it in 23 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Handelsbanken Fonder held 212,275 shares of Revolution Medicines worth $39.8M as of Q2 2026.
  • Handelsbanken Fonder bought 150,500 Revolution Medicines shares in Q2 2026, an estimated $22M.
  • Revolution Medicines made up 0.11% of Handelsbanken Fonder's portfolio in Q2 2026, its #144 holding.
  • Handelsbanken Fonder first reported a position in Revolution Medicines in Q4 2020 and has held it in 23 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.